Phase II trial of bevacizumab and everolimus in patients with advanced renal ... - UroToday PDF Print
UroTodayTwo groups of patients with metastatic renal cell carcinoma were eligible for this study: those with no previous treatment with targeted agents and those

... read more

 
Share |
Copyright © 2025 Global Dialysis. All Rights Reserved.